We assessed predictive abilities and clinical utility of CVD risk algorithms including ApoB and ApoAI among non-diabetic subjects with metabolic syndrome (MetS).
Gianfagna, F., Veronesi, G., Guasti, L., Chambless, L., Brambilla, P., Corrao, G., et al. (2014). Do apolipoproteins improve coronary risk prediction in subjects with metabolic syndrome? Insights from the North Italian Brianza cohort study. ATHEROSCLEROSIS, 236(1), 175-181 [10.1016/j.atherosclerosis.2014.06.029].
Do apolipoproteins improve coronary risk prediction in subjects with metabolic syndrome? Insights from the North Italian Brianza cohort study
BRAMBILLA, PAOLO;CORRAO, GIOVANNI;MANCIA, GIUSEPPE;CESANA, GIANCARLO;
2014
Abstract
We assessed predictive abilities and clinical utility of CVD risk algorithms including ApoB and ApoAI among non-diabetic subjects with metabolic syndrome (MetS).
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Apolipo coronary risk Monica 2014.pdf
Solo gestori archivio
Tipologia di allegato:
Submitted Version (Pre-print)
Dimensione
321.01 kB
Formato
Adobe PDF
|
321.01 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
